Clovis Oncology (CLVS) Posts Smaller Q2 Loss, Sales Beat
Get Alerts CLVS Hot Sheet
Join SI Premium – FREE
Clovis Oncology (NASDAQ: CLVS) reported Q2 EPS of ($1.29), $0.84 better than the analyst estimate of ($2.13). Revenue for the quarter came in at $14.62 million versus the consensus estimate of $13.31 million.
For earnings history and earnings-related data on Clovis Oncology (CLVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rexford Industrial Realty (REXR) Reports In-Line Q1 EPS, provides guidance
- Discover Financial Services (DFS) Reports Q1 EPS of $1.10
- Crown Castle (CCI) Tops Q1 EPS by 1c; maintains outlook for FY24
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!